Global Uro-Gynecological Surgical Devices Market – Industry Trends and Forecast to 2031

Analyse et taille du marché des dispositifs chirurgicaux uro-gynécologiques

Les chirurgies mini-invasives (CMI) jouent un rôle crucial sur le marché des dispositifs chirurgicaux uro-gynécologiques en offrant des alternatives moins invasives aux chirurgies ouvertes traditionnelles. Ces procédures utilisent des dispositifs spécialisés tels que des laparoscopes, des systèmes chirurgicaux robotisés et des instruments miniatures conçus pour une manipulation précise dans des espaces confinés comme la région pelvienne. La CMI en uro-gynécologie réduit les traumatismes chirurgicaux, la douleur postopératoire et les temps de récupération par rapport aux chirurgies ouvertes, ce qui permet aux patients de bénéficier d'une hospitalisation plus courte et d'un retour plus rapide à leurs activités normales.

Français La taille du marché mondial des dispositifs chirurgicaux uro-gynécologiques était évaluée à 26,76 milliards USD en 2023 et devrait atteindre 48,73 milliards USD d'ici 2031, avec un TCAC de 7,78 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché       

Définition du marché

Les dispositifs chirurgicaux uro-gynécologiques désignent les instruments et équipements spécialisés utilisés dans les interventions chirurgicales liées à l'urologie et à la gynécologie. Ces dispositifs sont conçus pour traiter des affections telles que l'incontinence urinaire, le prolapsus des organes pelviens et d'autres troubles affectant le plancher pelvien féminin. Ils comprennent des outils pour les chirurgies mini-invasives, les procédures diagnostiques et les interventions thérapeutiques visant à améliorer la santé pelvienne et à restaurer une fonction anatomique normale.

Dynamique du marché des dispositifs chirurgicaux uro-gynécologiques

Conducteurs                                                                                          

• Sensibilisation accrue des consommateurs

À mesure que de plus en plus de femmes sont informées sur les troubles uro-gynécologiques et les options de traitement disponibles, elles sont plus susceptibles de demander une aide médicale. Cette sensibilisation est alimentée par des campagnes de santé, un meilleur accès à l'information via Internet et des groupes de soutien. Par conséquent, la demande d'interventions chirurgicales et de dispositifs médicaux avancés augmente à mesure que de plus en plus de femmes optent pour ces traitements pour améliorer leur qualité de vie. Cette sensibilisation accrue réduit également la stigmatisation associée aux problèmes uro-gynécologiques, encourageant un diagnostic et un traitement rapides.

• Croissance de la population âgée

La population vieillissante est de plus en plus sujette à des pathologies telles que l'incontinence urinaire et le prolapsus des organes pelviens. À mesure que le nombre de personnes âgées augmente, la prévalence de ces troubles augmente, ce qui entraîne une demande accrue d'interventions chirurgicales. De plus, l'affaiblissement des muscles du plancher pelvien lié à l'âge nécessite des réparations chirurgicales, ce qui accroît le besoin de dispositifs chirurgicaux spécialisés. L'amélioration de l'accès aux soins de santé et l'allongement de l'espérance de vie contribuent également à la croissance du marché, car de plus en plus de patients âgés recherchent des traitements efficaces pour les problèmes uro-gynécologiques.

Opportunités

• Croissance des dépenses de santé

L’augmentation des dépenses permet aux établissements de santé d’investir dans des équipements de pointe, notamment des dispositifs chirurgicaux uro-gynécologiques avancés tels que des systèmes robotisés, des laparoscopes et des instruments spécialisés. Cet investissement renforce la capacité des hôpitaux et des cliniques à proposer des interventions chirurgicales mini-invasives , qui sont préférées pour leur temps de récupération réduit et leurs meilleurs résultats pour les patients. De plus, l’augmentation des dépenses de santé soutient la recherche et le développement dans le domaine, ce qui conduit à l’innovation dans les techniques chirurgicales et la technologie des dispositifs.

• Innovations technologiques en plein essor

Technological innovations advances surgical techniques and enhancing patient outcomes. Key innovations include the development of robotic-assisted surgery systems such as da Vinci Surgical System, which offer greater precision and control in complex uro-gynecological procedures. Imaging technologies such as 3D laparoscopy and intraoperative ultrasound improve visualization and surgical planning, reducing risks and improving surgical accuracy. Additionally, advancements in biomaterials for vaginal meshes and slings enhance durability and biocompatibility, improving long-term outcomes for patients.

Restraints/Challenges

• High Initial Costs

The advanced technology and specialized nature of these devices often result in substantial upfront expenses for healthcare facilities and providers. This can limit adoption rates, especially in regions with constrained healthcare budgets or where reimbursement for such procedures is inadequate. Additionally, the cost of maintenance, training, and updates further adds to the financial burden. High costs may deter smaller healthcare facilities from investing in state-of-the-art equipment, leading to disparities in access to advanced surgical treatments.

• Lack of Skilled Labour

Advanced surgical procedures and the use of sophisticated devices require specialized training and expertise among healthcare professionals. However, there is often a shortage of trained surgeons, nurses, and support staff proficient in operating these technologies effectively. This shortage can limit the adoption of minimally invasive surgeries and new surgical devices, as healthcare facilities may struggle to find and retain qualified personnel. Additionally, inadequate training programs and educational resources for uro-gynecological surgeries can further exacerbate the skills gap, hindering the widespread implementation and utilization of advanced surgical techniques.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Uro-Gynecological Surgical Devices Market Scope

The market is segmented on the basis product type, disease specific surgeries and procedure. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Uro- Gynaecological Surgical Devices
  • Urethral Stents
  • Sling and Suspension Devices
  • Endometrial Ablation Devices
  • Gynaecological Surgery Devices
• Trocars
  • Curettage Systems
  • Tubal Occlusion Systems
• Endoscopes
  • Cytoscope
  • Laparoscopes
  • Falloposcope
  • Fluid Management Systems

Disease Specific Surgeries

• Pelvic Organ Prolapse
• Urinary Incontinence
• Others

Basis of Procedure

• Dilation and Curettage Procedure
• Uterine Balloon Therapy
• Hysteroscopy Procedure
• Tubal Ligation Procedure
• Myomectomy Procedure

Uro-Gynecological Surgical Devices Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product type, disease specific surgeries and procedure as referenced above.      

The countries covered in the market report are the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.

North America dominates the market due to the region has a significant elderly population, which drives demand for treatments related to uro-gynecological conditions such as pelvic organ prolapse and urinary incontinence. This demographic trend creates a substantial market for surgical devices designed to address these issues. Additionally, North America benefits from advanced healthcare infrastructure and higher healthcare spending per capita, facilitating greater adoption of surgical interventions and innovative medical technologies. These factors combined contribute to the region's leadership in the development, adoption, and market share of uro-gynecological surgical devices compared to other global regions.

Asia-Pacific is expected to experience substantial growth in the market due to increasing awareness and healthcare infrastructure development. Rising incidences of urological and gynecological disorders among the population, coupled with growing healthcare expenditure and advancements in surgical technologies, are key drivers. Increased adoption of minimally invasive procedures and rising healthcare access in countries such as China, India, and Japan are further contributing factors. Market expansion is also supported by government initiatives promoting women's health and increasing investments by healthcare providers in advanced surgical equipment and techniques across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Uro-Gynecological Surgical Devices Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Boston Scientific Corporation (U.S.)
• Stryker (U.S.)
• Gyrus ACMI (U.S.)
• Cook (U.S.)
• CooperSurgical Inc. (U.S.)
• Millennium Surgical (U.S.)
• Narang Medical Limited (India)
• Medtronic (U.S.)
• Surgical Holdings (U.K.)
• MEDGYN PRODUCTS, INC. (U.S.)
• Sklar Surgical Instruments (U.S.)
• KLS Martin Group (Germany)
• Richard Wolf GmbH (Germany)
• KARL STORZ SE & Co. KG (Germany)
• Olympus Corporation (Japan)
• Johnson & Johnson Services, Inc. (U.S.)
• B. Braun SE (Germany)

SKU-63293